GDRX Company Profile and Key Details

Q: Who are the executives of GDRX?

Mr. Bansi NagjiPres of HealthcareMr. Raj BeriChief Operating OfficerMs. Vina M. LeiteChief People OfficerMs. Whitney NotaroVice President of Investor RelationsMr. Scott W. WagnerInterim Chief Executive OfficerMr. Karsten Ian VoermannChief Financial Officer & Principal Financial OfficerMr. Romin NabieyChief Accounting Officer & Principal Accounting OfficerMr. Trevor BezdekCo-founder & ChairmanMr. Justin FenglerSenior Vice President of Corporation Strategy & Bus. OperationsMr. Douglas Joseph HirschCo-founder, Chief Mission Officer & DirectorMr. Babak AzadChief Marketing Officer and Senior Vice President of Marketing & CommunicationsMr. Andrew SlutskyChief Marketing Officer

NASDAQ : GDRX

GoodRx

$3.06

0.18+6.25%

At Close 4:00 PM

66.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

GoodRx Holdings, Inc. (GDRX) stock surged +6.25%, trading at $3.06 on NASDAQ, up from the previous close of $2.88. The stock opened at $2.88, fluctuating between $2.86 and $3.14 in the recent session.

Stock Snapshot

2.88

Prev. Close

1.06B

Market Cap

2.855

Day Low

9.27

P/E Ratio

0.33

EPS (TTM)

0.2

Cash Flow per Share

2.88

Open

346.63M

Number of Shares

3.14

Day High

82.35%

Free Float in %

1.89

Book Value

2.07M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 01, 2026	2.86	3.14	2.86	3.06	2.07M
Jun 30, 2026	2.85	2.93	2.82	2.88	978.26K
Jun 29, 2026	2.83	2.88	2.80	2.85	1.24M
Jun 26, 2026	2.67	2.83	2.64	2.80	1.07M
Jun 25, 2026	2.75	2.79	2.69	2.69	745.64K
Jun 24, 2026	2.66	2.79	2.66	2.76	987.17K
Jun 23, 2026	2.51	2.67	2.50	2.67	707.59K
Jun 22, 2026	2.64	2.71	2.57	2.57	1.87M
Jun 18, 2026	2.63	2.68	2.63	2.66	2.1M
Jun 17, 2026	2.75	2.77	2.61	2.61	1.08M
Jun 16, 2026	2.72	2.77	2.68	2.73	1.39M
Jun 15, 2026	2.70	2.75	2.67	2.73	1.16M
Jun 12, 2026	2.62	2.66	2.59	2.65	673.63K
Jun 11, 2026	2.56	2.63	2.48	2.63	1.07M
Jun 10, 2026	2.61	2.67	2.54	2.56	1.12M
Jun 09, 2026	2.67	2.78	2.57	2.65	1.56M
Jun 08, 2026	2.70	2.70	2.63	2.63	749.77K
Jun 05, 2026	2.83	2.87	2.61	2.65	2.12M
Jun 04, 2026	2.84	3.02	2.83	2.85	1.33M
Jun 03, 2026	2.95	2.96	2.73	2.81	1.7M

Contact Details

Santa Monica, CA 90404

United States

https://www.goodrx.com 855 268 2822

About Company

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.

Stock Peers

BTSGU

0.84+0.37%

BrightSpring Health Services, Inc. Tangible Equity Unit$229.79 NUTX

19.82+11.60%

Nutex Health, Inc.$190.71 HQY

1.97+2.18%

HealthEquity, Inc.$92.29 WGS

3.06+4.46%

GeneDx Holdings Corp.$71.71 BTSG

0.11+0.16%

BrightSpring Health Services, Inc. Common Stock$69.85 GEHC

0.85+1.33%

GE HealthCare Technologies Inc.$64.86 TEM

3.67+6.34%

Tempus AI, Inc.$61.60 TXG

0.71+1.85%

10x Genomics, Inc.$39.05 HTFL

1.37+4.67%

Heartflow, Inc. Common Stock$30.71 PGNY

0.62+2.15%

Progyny, Inc.$29.45

Company Overview

GoodRx Holdings, Inc. (NASDAQ:GDRX) closed at $3.06 USD, gaining $0.18 (6.25%) from the previous close of $2.88. The stock is currently mid-range between its 52-week high and low $1.77 and $5.81. With a market capitalization of about $1.06 billion, GoodRx Holdings, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.61). Key stats such as the average daily volume over the past year has been around 1.52 million shares, in line with its 52-week average. Headquartered in Santa Monica, CA, GoodRx Holdings, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Wendy Barnes, the company employs approximately 738 people and listed since September 23, 2020. GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 -12.89%, SMA50 -21.52%, SMA200 -45.51%). The stock’s 14-day RSI is 36.89 (weak momentum), while the ATR of 0.18 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -65.75% below its high and over -5.24% above its low. Average 10-day trading volume of 1.21 million shares is below the 3-month average of 1.51 million, indicating normal recent market interest.

Valuation Metrics

GoodRx Holdings, Inc. trades at a P/E ratio of 53.11, slightly above the S&P 500 average, with a price-to-sales ratio of 1.37 and a price-to-book ratio of 1.7 suggesting the stock is closer to book value. The P/FCF stands at 9.22, also above market averages.

Dividend & Fair Value

GoodRx Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.52. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

GoodRx Holdings, Inc. generated EPS of $0.09 over the past year. Five-year average earnings growth is -17.73%. Wall Street analysts project EPS growth of 23.55% annually over the next five years. The latest quarter delivered EPS of $0.07. The next quarter is forecast at $0.10. Next year's EPS is expected at $13.27. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 5 Buy ratings, 6 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $7.00 to $2.75. The high target offers 128.76% upside. The low target suggests -10.13% downside. The mean target is $4.45. This offers 45.42% upside. GoodRx Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended May 06, 2026, missed forecasts by 0.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include -10.0% in February 27, 2025.

Shareholding & Insider Activity

GoodRx Holdings, Inc. has 98.58 million shares outstanding. The public float is 86.44 million shares, elevated short interest at 7.29% of float. This equals 6.37 million shares. The short ratio is 5.3 days. Institutional investors hold 71.91% of the float. Insiders own 12.67%. Abdiel Capital Management, LLC holds 8.06 million shares, Slutsky Andrew has 2.88 million shares and Wagner Scott has 182.90 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, GoodRx generated $750.27M in revenue, or $1.83 per share. Gross margin was 77.33%, operating margin 6.85%, and net profit margin -1.18%. Returns are negative, with ROA at -0.56% and ROE at -1.16%.
On valuation metrics, GoodRx trades at a P/E of 53.11, P/S of 1.37 and P/B of 1.70. The current ratio is 1.47 and quick ratio is 1.47. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 63.27 days. Debt-to-equity is 0.87, supported by a cash flow-to-debt ratio of 0.31.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, GoodRx posted revenue of $750.27M, down slightly from $766.55M in the prior quarter. Gross profit was $580.17M (margin 77.33%). Operating income was $51.38M (margin 6.8%). Net income was- $8.87M (EPS - $0.02).
The company ended the quarter with $672.30M in cash and short-term investments, a total debt of $711.07M, and net debt of $38.77M. Total assets were $1.59B, with equity of $761.96M. Financials further reflected stability, with operating cash flow of $138.29M, free cash flow of $82.53M, and capital expenditures of - $55.77M.

Price Forecast & Outlook

Our AI price prediction model suggests that GoodRx Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.54%, with price expected at $2.86 by July 14, 2026, within a range of $2.67 to $3.05 3-Month Outlook: Projected fall of -1.63%, reaching $3.01 by September 28, 2026, with a range of $2.77 to $3.18. 1-Year Outlook: Projected gain of 48.04%, with price at $4.53 by June 30, 2027, within a range of $0.00 to $4.37.

Key Takeaways

GoodRx Holdings, Inc. (NASDAQ:GDRX) shares are flat -4.06% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows GoodRx Holdings, Inc. trading at a premium to the broader market with a P/E of 53.11. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.52, suggesting 178.43% upside. Our AI forecast model points to short-term weakness (-6.54% over two weeks), a medium-term fall (-1.63% over three months), and a longer-term gain (48.04% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current GoodRx Holdings, Inc. (GDRX) stock price?

GoodRx Holdings, Inc. (NASDAQ: GDRX) stock price is $3.06 in the last trading session. During the trading session, GDRX stock reached the peak price of $3.14 while $2.86 was the lowest point it dropped to. The percentage change in GDRX stock occurred in the recent session was 6.25% while the dollar amount for the price change in GDRX stock was $0.18.

GDRX's industry and sector of operation?

The NASDAQ listed GDRX is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. GoodRx Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GDRX?

Mr. Bansi Nagji
Pres of Healthcare
Mr. Raj Beri
Chief Operating Officer
Ms. Vina M. Leite
Chief People Officer
Ms. Whitney Notaro
Vice President of Investor Relations
Mr. Scott W. Wagner
Interim Chief Executive Officer
Mr. Karsten Ian Voermann
Chief Financial Officer & Principal Financial Officer
Mr. Romin Nabiey
Chief Accounting Officer & Principal Accounting Officer
Mr. Trevor Bezdek
Co-founder & Chairman
Mr. Justin Fengler
Senior Vice President of Corporation Strategy & Bus. Operations
Mr. Douglas Joseph Hirsch
Co-founder, Chief Mission Officer & Director
Mr. Babak Azad
Chief Marketing Officer and Senior Vice President of Marketing & Communications
Mr. Andrew Slutsky
Chief Marketing Officer

How GDRX did perform over past 52-week?

GDRX's closing price is 72.88% higher than its 52-week low of $1.77 where as its distance from 52-week high of $5.81 is -47.33%.

How many employees does GDRX have?

Number of GDRX employees currently stands at 738.

Link for GDRX official website?

Official Website of GDRX is: https://www.goodrx.com

How do I contact GDRX?

GDRX could be contacted at phone 855 268 2822 and can also be accessed through its website. GDRX operates from 2701 Olympic Boulevard, Santa Monica, CA 90404, United States.

How many shares of GDRX are traded daily?

GDRX stock volume for the day was 2.07M shares. The average number of GDRX shares traded daily for last 3 months was 1.52M.

What is the market cap of GDRX currently?

The market value of GDRX currently stands at $1.06B with its latest stock price at $3.06 and 346.63M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	738
Beta	1.61
Sales or Revenue	$750.27M
5Y Sales Change%	1.609%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Information Services

GDRX Company Profile and Key Details

GoodRx

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Company Overview

Price Forecast & Outlook

Key Takeaways